The Pharmaceutical Genomics Division is focused on developing and applying novel functional genomics methods and high-throughput technologies to identify areas in the human genome that may be vulnerable to drug targets. These unique targets will then be advanced to develop the next generation of molecular medicines. Additionally, new cellular pharmacogenomic strategies have been developed at TGen to discover genes that regulate drug response. These discoveries will be advanced as biomarkers to predict clinical drug response to enable personalized medicine, in other words, getting the right drug to the right patient at the right time.

Cancer Drug Development Lab
Biological Therapeutics Lab
Knowledge-Mining & Bioinformatics Lab
Molecular Genetics Lab
Oncogenomics Lab
Chemogenomics Lab
High-Content Analysis Center